Citigroup’s Climb Bio, Inc. Common Stock CLYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2M | Sell |
1,611,887
-238,231
| -13% | -$295K | ﹤0.01% | 2041 |
|
|
2025
Q1 | $2.26M | Buy |
1,850,118
+1,827,387
| +8,039% | +$2.23M | ﹤0.01% | 1987 |
|
|
2024
Q4 | $40.9K | Buy |
22,731
+1,314
| +6% | +$2.37K | ﹤0.01% | 4288 |
|
|
2024
Q3 | $109K | Buy |
21,417
+19,785
| +1,212% | +$101K | ﹤0.01% | 3958 |
|
|
2024
Q2 | $11.6K | Buy |
+1,632
| New | +$11.6K | ﹤0.01% | 4365 |
|
|
2022
Q3 | – | Sell |
-53
| Closed | – | – | 5476 |
|
|
2022
Q2 | $0 | Sell |
53
-371
| -88% | – | ﹤0.01% | 5787 |
|
|
2022
Q1 | $4K | Sell |
424
-1,335
| -76% | -$12.6K | ﹤0.01% | 5098 |
|
|
2021
Q4 | $18K | Buy |
1,759
+953
| +118% | +$9.75K | ﹤0.01% | 4651 |
|
|
2021
Q3 | $14K | Buy |
+806
| New | +$14K | ﹤0.01% | 4630 |
|